Ma Bin, Ke Fa-Yong, Zheng Er-Liang, Yang Zun-Xian, Tang Qing-Nan, Qi Guo-Qing
Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, China Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou, Gansu, China.
Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, China The Frist School of Clinical Medicine of Lanzhou University, Lanzhou, China.
Acupunct Med. 2016 Jun;34(3):178-83. doi: 10.1136/acupmed-2015-010870. Epub 2016 Jan 6.
We aimed to assess the endorsement of the Consolidation Standards of Reporting Trials (CONSORT) statement by Chinese journals of Traditional Chinese Medicine (TCM) and its incorporation into their editorial processes.
PubMed, Embase and major Chinese databases were searched to identify journals of TCM from China for inclusion. The latest 'instruction for authors' (IFA) of each included journal was obtained and any text mentioning CONSORT or CONSORT extension papers was extracted. Subsequently, the editor of each of the included journals was surveyed about their journal's endorsement of the CONSORT recommendations and their incorporation into editorial and peer review processes.
Sixty-three journals of TCM from China were examined. Of these, only three (5%) and one (2%) of the 63 journals mentioned the CONSORT statement and extension papers, respectively, in their IFA. Fifty-four of 63 (86%) of surveyed journals responded, with the majority of respondents being editors. Only 20% (11/54) of the respondents reported that they had any knowledge of the CONSORT statement. Only 6% (3/54) of the editors reported that they required authors to comply with the CONSORT statement or that they incorporated it into their peer review and editorial processes.
TCM journals in China endorsing the CONSORT statement constituted a small percentage of the total. The majority of editors surveyed were not familiar with the content of the CONSORT statement and extension papers. We strongly recommend that the China Periodicals Association issue a policy to promote the endorsement of the CONSORT statement and conduct relevant training for journal editors in China.
我们旨在评估中国中医期刊对《试验报告的统一标准》(CONSORT)声明的认可情况及其在编辑流程中的纳入情况。
检索PubMed、Embase和主要的中文数据库,以确定纳入的中国中医期刊。获取每个纳入期刊的最新“作者须知”(IFA),并提取提及CONSORT或CONSORT扩展论文的任何文本。随后,对每个纳入期刊的编辑进行调查,了解其期刊对CONSORT建议的认可情况以及这些建议在编辑和同行评审流程中的纳入情况。
对63种中国中医期刊进行了检查。其中,63种期刊中分别只有3种(5%)和1种(2%)在其IFA中提及了CONSORT声明和扩展论文。63种期刊中有54种(86%)回复了调查,大多数受访者为编辑。只有20%(11/54)的受访者表示他们了解CONSORT声明。只有6%(3/54)的编辑报告称他们要求作者遵守CONSORT声明或将其纳入同行评审和编辑流程。
中国认可CONSORT声明的中医期刊占总数的比例较小。大多数接受调查的编辑不熟悉CONSORT声明和扩展论文的内容。我们强烈建议中国期刊协会发布一项政策,以促进对CONSORT声明的认可,并为中国的期刊编辑开展相关培训。